103 related articles for article (PubMed ID: 26319784)
1. Evaluation of Downstream Regulatory Element Antagonistic Modulator Gene in Human Multinodular Goiter.
Shinzato A; Lerario AM; Lin CJ; Danilovic DS; Marui S; Trarbach EB
Med Sci Monit Basic Res; 2015 Aug; 21():179-82. PubMed ID: 26319784
[TBL] [Abstract][Full Text] [Related]
2. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
[TBL] [Abstract][Full Text] [Related]
3. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
4. Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice.
Ruiz-DeDiego I; Mellstrom B; Vallejo M; Naranjo JR; Moratalla R
Biol Psychiatry; 2015 Jan; 77(2):95-105. PubMed ID: 24857398
[TBL] [Abstract][Full Text] [Related]
5. The DREAM protein is associated with thyroid enlargement and nodular development.
Rivas M; Mellström B; Torres B; Cali G; Ferrara AM; Terracciano D; Zannini M; Morreale de Escobar G; Naranjo JR
Mol Endocrinol; 2009 Jun; 23(6):862-70. PubMed ID: 19299442
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of DREAM gene mRNA levels in thyroid tumours.
Batista FA; Marcello MA; Martins MB; Peres KC; Cardoso UO; Silva ACDN; Bufalo NE; Soares FA; Silva MJD; Assumpção LV; Ward LS
Arch Endocrinol Metab; 2018; 62(2):205-211. PubMed ID: 29641740
[TBL] [Abstract][Full Text] [Related]
7. Ca2+-dependent regulation of calcitonin gene expression by the transcriptional repressor DREAM.
Matsuda M; Yamamoto TA; Hirata M
Endocrinology; 2006 Oct; 147(10):4608-17. PubMed ID: 16840549
[TBL] [Abstract][Full Text] [Related]
8. Lack of DREAM protein enhances learning and memory and slows brain aging.
Fontán-Lozano A; Romero-Granados R; del-Pozo-Martín Y; Suárez-Pereira I; Delgado-García JM; Penninger JM; Carrión AM
Curr Biol; 2009 Jan; 19(1):54-60. PubMed ID: 19110430
[TBL] [Abstract][Full Text] [Related]
9. H-RAS gene expression in human multinodular goiter.
Golbert L; Kolling JH; Leitão AH; Martins L; Kimura ET; Maia AL
Histol Histopathol; 2007 Apr; 22(4):409-16. PubMed ID: 17290351
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen-Deuterium Exchange Mass Spectrometry Reveals Calcium Binding Properties and Allosteric Regulation of Downstream Regulatory Element Antagonist Modulator (DREAM).
Zhang J; Li J; Craig TA; Kumar R; Gross ML
Biochemistry; 2017 Jul; 56(28):3523-3530. PubMed ID: 28627884
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional repressor DREAM is involved in thyroid gene expression.
D'Andrea B; Di Palma T; Mascia A; Motti ML; Viglietto G; Nitsch L; Zannini M
Exp Cell Res; 2005 Apr; 305(1):166-78. PubMed ID: 15777797
[TBL] [Abstract][Full Text] [Related]
12. Deep Sequencing Reveals Spatially Distributed Distinct Hot Spot Mutations in DICER1-Related Multinodular Goiter.
de Kock L; Bah I; Revil T; Bérubé P; Wu MK; Sabbaghian N; Priest JR; Ragoussis J; Foulkes WD
J Clin Endocrinol Metab; 2016 Oct; 101(10):3637-3645. PubMed ID: 27459524
[TBL] [Abstract][Full Text] [Related]
13. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
[TBL] [Abstract][Full Text] [Related]
14. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter.
Tonacchera M; Vitti P; Agretti P; Giulianetti B; Mazzi B; Cavaliere R; Ceccarini G; Fiore E; Viacava P; Naccarato A; Pinchera A; Chiovato L
Thyroid; 1998 Jul; 8(7):559-64. PubMed ID: 9709907
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression.
Savignac M; Pintado B; Gutierrez-Adan A; Palczewska M; Mellström B; Naranjo JR
EMBO J; 2005 Oct; 24(20):3555-64. PubMed ID: 16177826
[TBL] [Abstract][Full Text] [Related]
16. Building the DREAM interactome.
Rivas M; Villar D; González P; Dopazo XM; Mellstrom B; Naranjo JR
Sci China Life Sci; 2011 Aug; 54(8):786-92. PubMed ID: 21786202
[TBL] [Abstract][Full Text] [Related]
17. Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.
Kebebew E; Peng M; Treseler PA; Clark OH; Duh QY; Ginzinger D; Miner R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6105-11. PubMed ID: 15579766
[TBL] [Abstract][Full Text] [Related]
18. [DREAM: a multifunctional transcriptional regulator].
Fu ZB; Duan XB; Li LN; Lei XK; Jiang Y; Wang C; Xu HX; Zhang YL; Jiang JH; Chai RC; Jia XH; Yu ACH
Sheng Li Xue Bao; 2017 Oct; 69(5):703-714. PubMed ID: 29063118
[TBL] [Abstract][Full Text] [Related]
19. Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppression.
Sponziello ML; Bruno R; Durante C; D'Agostino M; Corradino R; Giannasio P; Ciociola E; Ferretti E; Maranghi M; Verrienti A; De Toma G; Filetti S; Russo D
Horm Metab Res; 2011 Jan; 43(1):22-5. PubMed ID: 20886414
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and management of multinodular goiter.
Hurley DL; Gharib H
Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
